West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $339.4 million versus the consensus estimate of $344.2 million.

West Pharmaceutical Services, Inc. sees FY2013 EPS of $3.05-3.20, versus the consensus of $3.13.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.

Earnings Guidance